SCHEMBL15087139

SCHEMBL15087139

C(=C/[Si](c1ccccc1)(c1ccccc1)c1ccccc1)\c1ccc(-c2ccc(N(c3cc(-c4ccccc4)cc(-c4ccccc4)c3)c3cc(-c4ccccc4)cc(-c4ccccc4)c3)cc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.36
MGLL Q99685 1/20 0.36
ALDH1A1 P00352 2/20 0.34
MAPT P10636 2/20 0.34
TDP1 Q9NUW8 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
MEN1 O00255 1/20 0.34
USP2 O75604 1/20 0.34
MAPK1 P28482 1/20 0.34
CTNNB1 P35222 1/20 0.34
KMT2A Q03164 1/20 0.34
ATM Q13315 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
RELA Q04206 1/20 0.34
CHEK1 O14757 2/20 0.34
HDAC2 Q92769 2/20 0.33
HDAC1 Q13547 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
BCHE P06276 1/20 0.32
APP P05067 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15087120 0.94 CA1 (0.40) CA1MGLLALDH1A1MAPTTDP1
SCHEMBL15087127 0.91 RELA (0.38) CA1MGLLALDH1A1MAPTTDP1
SCHEMBL15087137 0.90 CHEK1 (0.36) CA1MGLLALDH1A1MAPTTDP1
SCHEMBL15087199 0.90 CHEK1 (0.36) CA1MGLLALDH1A1MAPTTDP1
SCHEMBL15087170 0.89 RELA (0.41) CA1MGLLALDH1A1MAPTTDP1
SCHEMBL15087112 0.86 RELA (0.41) ALDH1A1MAPTTDP1L3MBTL1MEN1
SCHEMBL15087173 0.86 RELA (0.41) ALDH1A1MAPTTDP1L3MBTL1MEN1
SCHEMBL15087166 0.84 RELA (0.44) ALDH1A1MAPTTDP1L3MBTL1MEN1
SCHEMBL15087134 0.83 MEN1 (0.37) CA1MGLLALDH1A1MAPTTDP1
SCHEMBL7748544 0.82 CA1 (0.44) CA1MGLLALDH1A1MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9401481-B2 Compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2016-07-26 US disclosed
US-9401481-B2 Compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2016-07-26 US disclosed
US-20130168646-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2013-07-04 US disclosed
US-20130168646-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2013-07-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130168646-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME AOX1, OCIAD1, LEF1 CA1 2908/4885MGLL 970/4885ALDH1A1 22/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.